CNS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Reiterates Company is on Track to Achieve Milestones for Berubicin Potentially Pivotal Study Before Year End

berubicin (RTA 744) - CNS Pharma, WPD Pharma

Nov 15, 2023